Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics

Background: Cancer antigen 125 (CA125) is considered to have high sensitivity but poor specificity for ovarian cancer. New biomarkers utilized to early detect and monitor the progression of ovarian cancer patients are critically needed. Methods: A total of 80 patients including 16 early stage, and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjie, Xie, Hongyu, Xia, Bairong, Zhang, Liuchao, Hou, Yan, Li, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890305/
https://www.ncbi.nlm.nih.gov/pubmed/33613752
http://dx.doi.org/10.7150/jca.50733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890305/
https://www.ncbi.nlm.nih.gov/pubmed/33613752
http://dx.doi.org/10.7150/jca.50733

Ejemplares similares